|
Market Closed -
NYSE
16:00:00 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 2.800 USD | -1.41% |
|
+5.26% | +55.56% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 11 | +287.32% | 2 | |||||
| 1,325.39 | +13.27% | 29 | ||||||
| 277.91 | +3.24% | 22 | ||||||
| 278.61 | +5.05% | 28 | ||||||
| 375.34 | +3.09% | 19 | ||||||
| 152.43 | +7.5% | 22 | ||||||
| - | 211.41 | +25.05% | 23 | |||||
| 385.21 | -6.1% | 28 | ||||||
| 158.15 | +3.59% | 27 | ||||||
| 307.56 | +18.84% | 23 | ||||||
| 28.88 | +3.38% | 26 | ||||||
| 570.07 | +10.7% | 28 | ||||||
| 66.71 | +7.16% | 24 | ||||||
| 94.06 | +26.44% | 24 | ||||||
| 21.71 | +13.9% | 21 | ||||||
| 9,323.33 | +38.21% | 15 | ||||||
| 6,622.06 | +10.96% | 16 | ||||||
| 58.22 | +17.5% | 18 | ||||||
| 71.35 | +56.07% | 17 | ||||||
| Average | 1,070.49 | +28.69% | 22 | ||||||
| Weighted average by Cap. | 725.93 | +9.92% | 25 |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
